The implementation of EU and UK Novel Food regulations (which are stringent regulations to demonstrate safety) is a positive step in the right direction for the CBD market, as it aims to provide consumers with the necessary reassurance that they are receiving, high quality, fully certified CBD products. To achieve a license, CBD companies are now required to undergo extensive analytical and clinical safety studies, ensuring products are safe to use and compliant.

Co Founder and CSO, Caroline Glynn will explain why this legislation is being implemented, what this means for CBD companies and where it leaves Pureis®.

(10 minutes, 6 slides)